Gastric Balloons - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-06-01 I 114 Pages I Mordor Intelligence
Gastric Balloons Market Analysis
The gastric balloons market size stands at USD 77.66 million in 2025 and is forecast to reach USD 146.31 million by 2030, reflecting a sound 13.51% CAGR. Accelerating obesity prevalence, procedureless balloon innovations, and rising payer openness to cover reversible therapies fuel this growth. Demand is strongest among individuals with body mass index (BMI) 30-40 kg/m who reject surgery but seek durable weight control, while clinicians increasingly view balloons as a bridge between lifestyle change and bariatric surgery. Technological advances such as swallowable capsules, soft-robotic pressure adjustment, Internet-of-Things (IoT) telemetry, and concurrent glucagon-like peptide-1 (GLP-1) pharmacotherapy showcase how device makers intend to improve efficacy, comfort, and metabolic impact.
Global Gastric Balloons Market Trends and Insights
Rising Prevalence of Obesity
Obesity has been reclassified as a chronic disease requiring formal medical intervention. The United States' 2024 proposal to reimburse anti-obesity drugs under Medicare Part D signals institutional recognition that fuels demand for complementary device-based options. Health systems see balloons as a cost-effective route to mitigate diabetes, hypertension, and sleep-apnea expenditures. Meta-analyses indicate 55.5% resolution in type 2 diabetes, 58.8% in hypertension, and 57.8% in obstructive sleep apnea within four months of balloon therapy. Rising adolescent obesity opens a younger segment that favours reversible, nonsurgical tools.
Increasing Demand for Minimally-invasive Weight-loss Procedures
Patients increasingly seek interventions that avoid surgery, preserve future options, and permit swift return to routine. Procedureless balloons eliminate sedation, operating theatre time, and the need for gastroenterologist supervision, making therapy accessible in primary-care settings. Swallowable devices show serious adverse events under 3.1%, favourably contrasting with surgical complication profiles. Outpatient-friendly workflows widen provider networks, encouraging rapid adoption despite endoscopy's current 74% share dominance.
Limited Long-term Efficacy versus Bariatric Surgery
Weight regain after device removal remains a core concern. Evidence shows only 44.7% of balloon patients keep meaningful loss 12 months post-extraction, whereas laparoscopic sleeve gastrectomy delivers better durability ajendoscopicsurg.org. This limitation narrows the eligible cohort to individuals prioritising reversibility over maximal weight reduction. Long-term nutritional counselling and digital coaching add cost and complexity.
Other drivers and restraints analyzed in the detailed report include:
Combination Therapy with GLP-1 Agonists Unlocking New Indications / Growing Clinical Evidence Base & Guideline Endorsements / Competitive Threat from Next-generation Endoscopic Sleeve Gastroplasty /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
In 2024, single devices controlled 68.1% of the gastric balloons market, underwritten by decades of safety data and straightforward placement requirements. Orbera's lineage illustrates sustained physician confidence, which translates into predictable revenue for hospitals and clinics. Patients often select singles for lower cost and well-documented outcomes. Market incumbents reinforce this position by bundling balloons with nutrition coaching apps that maximise post-procedure support.
Triple-balloon systems record the highest 13.62% CAGR and illustrate how innovation can command premium reimbursement. Spatz's adjustable platform lets physicians modulate volume to counter weight-loss plateaus, achieving 15% total body weight loss in controlled trials. This adaptability differentiates triple balloons in performance-driven patient segments and signals a route to extend indwell time, potentially mitigating the long-term efficacy gap.
Saline remains the default fill, occupying 81.67% share in 2024 due to radiographic visibility and long-term safety documentation. Hospitals appreciate the control saline affords during placement and removal, which aligns with standard endoscopy workflow. Moreover, device suppliers maintain mature supply chains for sterile saline kits, supporting cost efficiency.
Gas-filled balloons, led by Obalon, advance at 13.72% CAGR as patients value lighter intragastric load and reduced nausea. Swallowable capsule delivery eliminates sedation and can be completed in under 15 minutes, a major draw for outpatient settings. Despite slightly longer removal duration, improved tolerability supports broader adoption, particularly in primary-care networks seeking scalable interventions.
The Gastric Balloons Market is Segmented by Product Type (Single Gastric Balloons, Dual Gastric Balloons, and More), Filling Materials (Saline Filled Balloons and Gas Filled Balloons), Insertion Method (Endoscopic and Oral), End User (Hospitals, Bariatric & Metabolic Clinics, and More) and Geography (North America, Europe, Asia-Pacific, and More). The Report Offers the Value (in USD) for the Above Segments.
Geography Analysis
North America accounted for 40.21% of the gastric balloons market in 2024, boosted by FDA-cleared device variety and strong clinician awareness. Medicare's evolving coverage stance and employer wellness initiatives keep demand resilient.
Europe maintains significant weight through broad physician adoption and proactive guideline inclusion. Reimbursement, however, remains patchy, producing a mosaic of regional uptake-Germany's statutory insurers reimburse balloons selectively, whereas southern Europe often relies on self-pay models.
Asia Pacific exhibits a 13.92% CAGR, the fastest globally. Rising disposable incomes and surging obesity prevalence create favourable demand in China, Japan, and India. Japan's 15-year registry shows 46.6% mean excess weight loss, instilling confidence among regional gastroenterologists. Yet payer fragmentation and offshore medical tourism mean market development leans toward private-sector hospitals and wellness chains that target affluent urban populations.
List of Companies Covered in this Report:
Boston Scientific / Allurion Technologies / ReShape Lifescience / Spatz FGIA, Inc. / Helioscopie Medical Implants / Districlass Medical / Silimed / ENDALIS / LEXEL / Medispar CVBA / Medsil / Izsam Medical / ReShape Duo (ReShape Medical) / Heliosphere Bag (Heliosphere) / Ullorex Medical / Semistationary Antral Balloon (SAB) / Medicone /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Obesity
4.2.2 Increasing Demand for Minimally-invasive Weight-loss Procedures
4.2.3 Growing Clinical?evidence Base & Guideline endorsements
4.2.4 Expanding Reimbursement Coverage in Key Markets
4.2.5 Combination Therapy with GLP-1 Agonists Unlocking New Indications
4.2.6 Smart/adjustable Balloons Enabled by Soft-robotics & IoT Tracking
4.3 Market Restraints
4.3.1 Limited Long-term Efficacy versus Bariatric Surgery
4.3.2 Adverse-event Profile (Early deflation, pancreatitis, migration)
4.3.3 Patchwork Reimbursement in Emerging Economies
4.3.4 Competitive Threat from Next-generation Endoscopic Sleeve Gastroplasty
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Buyers
4.7.3 Bargaining Power of Suppliers
4.7.4 Threat of Substitute Products
4.7.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value)
5.1 By Product Type
5.1.1 Single Gastric Balloons
5.1.2 Dual Gastric Balloons
5.1.3 Triple Gastric Balloons
5.2 By Filling Material
5.2.1 Saline-Filled Balloons
5.2.2 Gas-Filled Balloons
5.3 By Insertion Method
5.3.1 Endoscopic Placement
5.3.2 Swallowable / Pill-Form (Oral)
5.4 By End User
5.4.1 Hospitals
5.4.2 Bariatric & Metabolic Clinics
5.4.3 Ambulatory Surgical Centers
5.5 Geography
5.5.1 North America
5.5.2 Europe
5.5.3 Asia-Pacific
5.5.4 Middle East & Africa
5.5.5 South America
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles
6.3.1 Boston Scientific Corporation
6.3.2 Allurion Technologies, Inc.
6.3.3 Reshape Lifesciences Inc.
6.3.4 Spatz FGIA, Inc.
6.3.5 Helioscopie Medical Implants
6.3.6 Districlass Medical SA
6.3.7 Silimed, Inc.
6.3.8 ENDALIS
6.3.9 LEXEL S.R.L
6.3.10 Medispar CVBA
6.3.11 Medsil
6.3.12 Izsam Medical
6.3.13 ReShape Duo (ReShape Medical)
6.3.14 Heliosphere Bag (Heliosphere)
6.3.15 Ullorex Medical
6.3.16 Semistationary Antral Balloon (SAB)
6.3.17 Medicone
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.